ASTHNasdaqServices-Management Consulting ServicesFiscal year ends December 31
Astrana Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$36.90+0.09 (+0.24%)
Close on Oct 19, 2026
- Market cap
- $1.84B
- P/E (TTM)
- 45.0
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
57.7%
32M of 56M shares
Institutional holders
209
58 new, 17 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 6,234,446 | 12.40% | 13G (passive) amendment | Mar 31, 2025 |
| Allied Physicians of California, a Professional Medical Corporation | 6,132,802 | 11.00% | 13D (active) amendment | Feb 15, 2025 |
| Vanguard Portfolio Management | 2,648,939 | 5.34% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ASTH | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6,899,990 | 12.38% | $320.23M | +736,263 | 0.00% |
| Vanguard Portfolio Management LLC | 2,605,775 | 4.68% | $120.93M | +328,969 | 0.01% |
| Vanguard Capital Management LLC | 1,946,431 | 3.49% | $90.33M | +236,169 | 0.00% |
| State Street Corp | 1,738,930 | 3.12% | $80.70M | +88,440 | 0.00% |
| 325 Capital LLC | 1,613,843 | 2.90% | $74.90M | −225,233 | 17.85% |
| Dimensional Fund Advisors LP | 1,468,508 | 2.63% | $68.15M | +100,429 | 0.01% |
| Wellington Management Group Llp | 1,292,573 | 2.32% | $59.99M | −49,251 | 0.01% |
| Geode Capital Management, LLC | 1,167,974 | 2.10% | $54.22M | +129,889 | 0.00% |
| Bank Of America Corp /De/ | 852,145 | 1.53% | $39.55M | +277,416 | 0.00% |
| FMR LLC | 685,922 | 1.23% | $31.83M | +269,797 | 0.00% |
| Wells Fargo & Company/Mn | 664,940 | 1.19% | $30.86M | +561,941 | 0.00% |
| Charles Schwab Investment Management Inc | 652,669 | 1.17% | $30.29M | +8,498 | 0.00% |
| Ameriprise Financial Inc | 512,110 | 0.92% | $23.77M | −39,489 | 0.00% |
| Northern Trust Corp | 505,044 | 0.91% | $23.44M | +66,881 | 0.00% |
| Diamond Hill Capital Management Inc | 475,941 | 0.85% | $22.09M | −68,093 | 0.18% |
| Royce & Associates LP | 472,480 | 0.85% | $21.93M | +75,519 | 0.18% |
| SteelPeak Wealth, LLC | 464,937 | 0.83% | $21.58M | −95,000 | 0.56% |
| Morgan Stanley | 433,508 | 0.78% | $20.12M | +94,705 | 0.00% |
| Invesco Ltd. | 381,830 | 0.69% | $17.72M | +30,718 | 0.00% |
| Vanguard Fiduciary Trust Co | 307,022 | 0.55% | $14.25M | +14,019 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 209 | 32M | 57.7% | 58 / 81 | 49 / 17 | 5M | 3M |
| Q1 2026 | 171 | 30M | 53.7% | 27 / 64 | 54 / 28 | 7M | 2M |
| Q4 2025 | 176 | 29M | 52.3% | 38 / 56 | 66 / 43 | 4M | 2M |
| Q3 2025 | 188 | 27M | 48.1% | 48 / 65 | 56 / 21 | 3M | 2M |
| Q2 2025 | 162 | 26M | 46.8% | 32 / 53 | 55 / 35 | 2M | 2M |
| Q1 2025 | 168 | 26M | 47.0% | 21 / 58 | 59 / 31 | 2M | 2M |
| Q4 2024 | 179 | 26M | 46.8% | 31 / 68 | 54 / 41 | 3M | 2M |
| Q3 2024 | 189 | 25M | 45.5% | 32 / 69 | 58 / 14 | 10M | 1M |
| Q2 2024 | 172 | 23M | 41.5% | 30 / 64 | 48 / 15 | 2M | 2M |
| Q1 2024 | 159 | 24M | 42.3% | 28 / 50 | 51 / 12 | 1M | 1M |
| Q4 2023 | 143 | 23M | 40.7% | 22 / 47 | 51 / 12 | 2M | 1M |
| Q3 2023 | 134 | 22M | 38.6% | 16 / 52 | 46 / 12 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ASTH | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 2,558,015 | 4.59% | $118.72M | 0.11% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1,416,817 | 2.54% | $65.75M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,186,705 | 2.13% | $55.07M | 0.07% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 1,021,229 | 1.83% | $47.40M | 0.03% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 591,784 | 1.06% | $27.46M | 0.06% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 499,026 | 0.90% | $17.75M | 0.05% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 487,318 | 0.87% | $22.62M | 0.02% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 421,171 | 0.76% | $19.55M | 0.13% | Jun 30, 2026 |
| Diamond Hill Small Cap Fund | 411,996 | 0.74% | $19.12M | 6.21% | Jun 30, 2026 |
| Select Health Care Services Portfolio | 397,590 | 0.71% | $14.96M | 1.85% | May 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 390,080 | 0.70% | $18.10M | 0.11% | Jun 30, 2026 |
| iShares S&P Small-Cap 600 Value ETF | 365,485 | 0.66% | $16.96M | 0.21% | Jun 30, 2026 |
| Fidelity Small Cap Growth Fund | 318,530 | 0.57% | $11.33M | 0.13% | Jul 31, 2026 |
| Vanguard Tax-Managed Small-Cap Fund | 303,692 | 0.54% | $14.09M | 0.12% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 223,583 | 0.40% | $8.41M | 0.02% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Kenneth T. Sim | Executive Chairman, Director | 7,692,242 | 13.80% | Apr 8, 2026 |
| John Vong | SVP - Accounting (PAO) | 22,330 | 0.04% | Sep 17, 2026 |
| Brandon Sim | CEO and President | 1,890,501 | 3.39% | Sep 9, 2026 |
| Chandan Basho | COO and CFO | 157,820 | 0.28% | Sep 8, 2026 |
| Dinesh M. Kumar | Chief Medical Officer | 177,655 | 0.32% | Apr 3, 2026 |
| Mitchell W. Kitayama | Director | 24,337 | 0.04% | Sep 1, 2026 |
| David Schmidt | Director | 56,019 | 0.10% | Aug 18, 2026 |
| Dai, Weili | Director | 18,188 | 0.03% | Jun 12, 2026 |
| John Chiang | Director | 35,373 | 0.06% | Jun 12, 2026 |
| Linda Dong | Director | 97,133 | 0.17% | Jun 12, 2026 |
| Matthew Mazdyasni | Director | 39,288 | 0.07% | Jun 12, 2026 |
| Thomas S. Lam | Director | 7,732,165 | 13.87% | Apr 8, 2026 |
| Glenn Sobotka | – | 2,246 | 0.00% | Aug 11, 2026 |
| ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp | 10% owner | 6,132,802 | 11.00% | Feb 18, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| John Vong SVP - Accounting (PAO) | Sep 15, 2026 | Tax withholding | −96 | $38.35 | $3.68K | 22,330 |
| Brandon Sim CEO and President | Sep 5, 2026 | Tax withholding | −7,163 | $38.47 | $275.56K | 1,238,861 |
| Chandan Basho COO and CFO | Sep 5, 2026 | Tax withholding | −1,790 | $38.47 | $68.86K | 157,820 |
| Mitchell W. Kitayama Director | Aug 31, 2026 | Returned to company | −8,500 | $37.09 | $315.27K | 24,337 |
| David Schmidt Director | Aug 14, 2026 | Option exercise | +20,000 | $5.00 | $100.00K | 56,019 |
| David Schmidt Director | Aug 14, 2026 | Returned to company | −20,000 | $38.59 | $771.80K | 36,019 |
| Glenn Sobotka – | Aug 7, 2026 | Returned to company | −11,793 | – | – | 2,246 |
| Brandon Sim CEO and President | Jun 27, 2026 | Tax withholding | −1,093 | $44.51 | $48.65K | 1,245,292 |
| David Schmidt Director | Jun 10, 2026 | Award | +4,525 | – | – | 36,019 |
| Dai, Weili Director | Jun 10, 2026 | Award | +4,525 | – | – | 18,188 |
| Matthew Mazdyasni Director | Jun 10, 2026 | Award | +4,525 | – | – | 39,288 |
| Mitchell W. Kitayama Director | Jun 10, 2026 | Award | +4,991 | – | – | 32,837 |
| John Chiang Director | Jun 10, 2026 | Award | +4,525 | – | – | 35,373 |
| Linda Dong Director | Jun 10, 2026 | Award | +4,525 | – | – | 97,133 |
| Chandan Basho COO and CFO | May 16, 2026 | Tax withholding | −8,155 | $38.26 | $312.01K | 159,610 |
| Chandan Basho COO and CFO | Apr 14, 2026 | Tax withholding | −3,870 | $29.07 | $112.50K | 167,765 |
| Kenneth T. Sim Executive Chairman, Director | Apr 6, 2026 | Award | +100,000 | – | – | 739,407 |
| Brandon Sim CEO and President | Apr 6, 2026 | Award | +201,056 | – | – | 1,246,385 |
| Thomas S. Lam Director | Apr 6, 2026 | Award | +41,667 | – | – | 465,657 |
| Chandan Basho COO and CFO | Apr 2, 2026 | Tax withholding | −2,092 | $25.05 | $52.40K | 171,635 |
| Dinesh M. Kumar Chief Medical Officer | Apr 1, 2026 | Tax withholding | −57,980 | $24.51 | $1.42M | 177,655 |
| Dinesh M. Kumar Chief Medical Officer | Apr 1, 2026 | Award | +35,300 | – | – | 235,635 |
| Glenn Sobotka Chief Accounting Officer | Mar 26, 2026 | Tax withholding | −662 | $24.27 | $16.07K | 14,039 |
| Dinesh M. Kumar Chief Medical Officer | Mar 5, 2026 | Tax withholding | −1,697 | $25.07 | $42.54K | 200,335 |
| Chandan Basho COO and CFO | Mar 5, 2026 | Tax withholding | −1,240 | $25.07 | $31.09K | 173,727 |
| Thomas S. Lam Director | Mar 5, 2026 | Tax withholding | −9,266 | $25.07 | $232.30K | 423,990 |
| Brandon Sim CEO and President | Feb 2, 2026 | Option exercise | +21,334 | $23.24 | $495.80K | 1,045,329 |
| Dinesh M. Kumar Chief Medical Officer | Jan 23, 2026 | Tax withholding | −10,759 | $27.16 | $292.21K | 202,032 |
| David Schmidt Director | Jan 13, 2026 | Option exercise | +20,000 | $5.79 | $115.80K | 35,763 |
| David Schmidt Director | Jan 13, 2026 | Tax withholding | −4,269 | $27.12 | $115.78K | 31,494 |
| Dinesh M. Kumar Chief Medical Officer | Jan 1, 2026 | Tax withholding | −5,102 | $24.81 | $126.58K | 212,791 |
| Thomas S. Lam Director | Dec 8, 2025 | Tax withholding | −25,866 | $22.00 | $569.05K | 433,256 |
| Thomas S. Lam Director | Dec 8, 2025 | Option exercise | +29,502 | $17.78 | $524.55K | 459,122 |
| Kenneth T. Sim Executive Chairman, Director | Nov 10, 2025 | Option exercise | +29,502 | $17.78 | $524.55K | 639,407 |
| Matthew Mazdyasni Director | Nov 10, 2025 | Option exercise | +20,000 | $18.20 | $364.00K | 34,763 |
| Mitchell W. Kitayama Director | Nov 7, 2025 | Option exercise | +12,000 | $18.20 | $218.40K | 27,846 |
| Linda Dong Director | Nov 3, 2025 | Option exercise | +20,000 | $18.20 | $364.00K | 103,641 |
| Linda Dong Director | Nov 3, 2025 | Tax withholding | −11,033 | $32.99 | $363.98K | 92,608 |
| Chandan Basho COO and CFO | Oct 2, 2025 | Tax withholding | −1,979 | $27.77 | $54.96K | 174,967 |
| Mitchell W. Kitayama Director | Sep 15, 2025 | Returned to company | −5,214 | $30.23 | $157.62K | 15,846 |
| Mitchell W. Kitayama Director | Sep 15, 2025 | Returned to company | −8,000 | $30.23 | $241.84K | 21,060 |
| Mitchell W. Kitayama Director | Sep 15, 2025 | Option exercise | +8,000 | $18.20 | $145.60K | 29,060 |
| Chandan Basho COO and CFO | Sep 5, 2025 | Tax withholding | −1,694 | $29.70 | $50.31K | 176,946 |
| Dinesh M. Kumar Chief Medical Officer | Sep 5, 2025 | Tax withholding | −1,694 | $29.70 | $50.31K | 217,893 |
| David Schmidt Director | Sep 2, 2025 | Returned to company | −20,000 | $27.76 | $555.20K | 15,763 |
| David Schmidt Director | Sep 2, 2025 | Option exercise | +20,000 | $18.20 | $364.00K | 35,763 |
| John Chiang Director | Aug 13, 2025 | Option exercise | +20,000 | $18.20 | $364.00K | 43,132 |
| John Chiang Director | Aug 13, 2025 | Tax withholding | −12,284 | $29.63 | $363.97K | 30,848 |
| Dinesh M. Kumar Chief Medical Officer | Jul 1, 2025 | Tax withholding | −6,831 | $25.06 | $171.18K | 218,811 |
| Linda Dong Director | Jun 11, 2025 | Award | +6,449 | – | – | 83,641 |
| David Schmidt Director | Jun 11, 2025 | Award | +6,449 | – | – | 15,763 |
| John Chiang Director | Jun 11, 2025 | Award | +6,449 | – | – | 23,132 |
| Mitchell W. Kitayama Director | Jun 11, 2025 | Award | +6,449 | – | – | 21,060 |
| Dai, Weili Director | Jun 11, 2025 | Award | +6,449 | – | – | 13,663 |
| Matthew Mazdyasni Director | Jun 11, 2025 | Award | +6,449 | – | – | 14,763 |
| Dinesh M. Kumar Chief Medical Officer | Jun 4, 2025 | Tax withholding | −1,656 | $25.06 | $41.50K | 225,642 |
| Chandan Basho COO and CFO | May 16, 2025 | Tax withholding | −10,035 | $27.18 | $272.75K | 178,640 |
| Dinesh M. Kumar Chief Medical Officer | Apr 29, 2025 | Tax withholding | −828 | $31.15 | $25.79K | 227,298 |
| Chandan Basho COO and CFO | Apr 14, 2025 | Tax withholding | −2,683 | $34.05 | $91.36K | 188,675 |
| Chandan Basho COO and CFO | Apr 2, 2025 | Tax withholding | −1,394 | $30.02 | $41.85K | 191,358 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.